Skip to main content
Fig. 9 | BMC Immunology

Fig. 9

From: Integrated bulk RNA sequencing and mass cytometry analysis reveal the circulating immune landscape in ischemic and hemorrhagic Moyamoya disease

Fig. 9

Overview of imaging mass cytometry on DCs in ischemic and hemorrhagic MMD patients. (A) Representative t-SNE plot of seven DC clusters from MMD patients. (B) t-SNE heatmap of cluster markers. (C) Donut chart showing DC subset proportions in ischemic and hemorrhagic MMD patients. (D) Bar chart comparing DC subset proportions between ischemic and hemorrhagic groups. (E) Heatmap showing protein expression levels across DC clusters. (F) Expression differences of CX3CR1 between ischemic and hemorrhagic groups in DC clusters. (G) Differential molecular expression between ischemic and hemorrhagic groups in DC01, DC03, DC06 clusters. Significance: ns, p ≥ 0.05; *p < 0.05

Back to article page